Cancer clinical trial eligibility criteria: patients with organ dysfunction or prior or concurrent malignancies
Information
Type
International scientific guidelines adopted in Australia
Regulated products
Medical Devices
Topics
Clinical Trials, Medicines Safety, Prescription Medicines, Therapeutic Goods Regulation
Published
July 17, 2024
Last updated
July 17, 2024
Description
We have adopted this International Scientific Guideline - FDA-2019-D-0359
Tags
Organization
Country / Region
Australia
License
Other (Non-Commercial)